Drugs used in chemotherapy. Chemotherapy session for neoplasm
Conditions
Interventions
Intervention 1: Intervention group: All patients have a single-lumen Polysite(Vygon) catheter. Catheters are used for the purposes of chemotherapy and the transfer of blood and serum products and oth
Sponsors
Iran University of Medical Sciences
Eligibility
Sex/Gender
All
Age
1 Months to 19 Years
Inclusion criteria
Inclusion criteria: Children who have recently been diagnosed with malignancy requiring chemotherapy Children who need Port-a-Cath for treatment of malignancy, not only transfusion. Consent of patients' parents and implicit consent of children with decision-making capacity Children Aged between 1 month to 19 years
Exclusion criteria
Exclusion criteria: Having congenital coagulation disorder Having non-tunneled Port-a-Cath History of congenital hematologic disorders
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Serum Interleukin-6 level. Timepoint: Before intervention, 1 month after entering the study and 6 month after entring. Method of measurement: Patients' serologic examinations; the serum IL-6 level will be measured in pg/dl.;Duration of Port-a-Cath function. Timepoint: On the first medical contact and then every chemotherapy session or every month (whichever is earlier) up to 6 months. Method of measurement: The number of days that the port catheter has had a diagnostic or therapeutic function so that blood and fluids can move in both directions. | — |
Secondary
| Measure | Time frame |
|---|---|
| Serum CRP level. Timepoint: At the beginning of the study the 1 month later and 6 months later. Method of measurement: Serum CRP level will be measured by serologic examinations. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactAziz Egbali
Iran University of Medical Sciences
Outcome results
None listed